Clinical Trial: Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting Conditions

U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07260851) titled 'Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting Conditions' on Nov. 16.

Brief Summary: This study aims to evaluate the safety and pharmacokinetic characteristics of DWJ1622, DWC202313, and DWC202314 in healthy adult volunteers under fasting conditions.

Study Start Date: Nov. 05

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: DWJ1622

DWJ1622 (single oral dose) is administered in accordance with the study protocol.

DRUG: DWC202313, DWC202314

DWC202313, DWC202314(single oral dose) is administered in accordance with...